Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion
Nishant Ranjan Chauhan,
Soumya Kundu,
Ramyasingh Bal,
Diya Chattopadhyay,
Rinku Sahu,
Subhash Mehto,
Rina Yadav,
Sivaram Krishna,
Kautilya Kumar Jena,
Sameekshya Satapathy,
Anusha Pv,
Krushna C. Murmu,
Bharati Singh,
Srinivas Patnaik,
Sarita Jena,
Krishnan H. Harshan,
Gulam Hussain Syed,
Mohammed M. Idris,
Punit Prasad,
Santosh Chauhan
Affiliations
Nishant Ranjan Chauhan
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India; Corresponding author
Soumya Kundu
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India
Ramyasingh Bal
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India; School of Biotechnology, KIIT University, Bhubaneswar, India
Diya Chattopadhyay
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India
Rinku Sahu
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India; Regional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, India
Subhash Mehto
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India
Rina Yadav
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India; Regional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, India
Sivaram Krishna
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India; Regional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, India
Kautilya Kumar Jena
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India
Sameekshya Satapathy
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India
Anusha Pv
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India
Krushna C. Murmu
Epigenetic and Chromatin Biology Unit, Institute of Life Sciences, Bhubaneswar 751023, India
Bharati Singh
Virus-Host Interactions Lab, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, Odisha, India
Srinivas Patnaik
School of Biotechnology, KIIT University, Bhubaneswar, India
Sarita Jena
Experimental Animal Facility, Institute of Life Sciences, Bhubaneswar 751023, India
Krishnan H. Harshan
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India
Gulam Hussain Syed
Virus-Host Interactions Lab, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, Odisha, India
Mohammed M. Idris
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India
Punit Prasad
Epigenetic and Chromatin Biology Unit, Institute of Life Sciences, Bhubaneswar 751023, India
Santosh Chauhan
Cell Biology and Infectious Diseases Unit, Department of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar 751023, India; CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana 500007, India; Corresponding author
Summary: Type I interferon (IFN-I) response is the first line of host defense against invading viruses. In the absence of definite mouse models, the role of IFN-I in SARS-CoV-2 infection remains perplexing. Here, we develop two mouse models, one with constitutively high IFN-I response (hACE2; Irgm1−/−) and the other with dampened IFN-I response (hACE2; Ifnar1−/−), to comprehend the role of IFN-I response. We report that hACE2; Irgm1−/− mice are resistant to lethal SARS-CoV-2 infection. In contrast, a severe SARS-CoV-2 infection along with immune cell infiltration, cytokine storm, and enhanced pathology is observed in the lungs and brain of hACE2; Ifnar1−/− mice. The hACE2; Irgm1−/−Ifnar1−/− double-knockout mice display loss of the protective phenotype observed in hACE2; Irgm1−/− mice, suggesting that heightened IFN-I response accounts for the observed immunity. Taking the results together, we demonstrate that IFN-I protects from lethal SARS-CoV-2 infection, and Irgm1 (IRGM) could be an excellent therapeutic target against SARS-CoV-2.